These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 177869

  • 1. Myocardial infarction and estrogen therapy in post-menopausal women.
    Rosenberg L, Armstrong B, Jick H.
    N Engl J Med; 1976 Jun 03; 294(23):1256-9. PubMed ID: 177869
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.
    Wilson PW, Garrison RJ, Castelli WP.
    N Engl J Med; 1985 Oct 24; 313(17):1038-43. PubMed ID: 2995808
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Menopause and the risk of coronary heart disease in women.
    Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH.
    N Engl J Med; 1987 Apr 30; 316(18):1105-10. PubMed ID: 3574358
    [Abstract] [Full Text] [Related]

  • 8. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.
    Heckbert SR, Weiss NS, Koepsell TD, Lemaitre RN, Smith NL, Siscovick DS, Lin D, Psaty BM.
    Arch Intern Med; 1997 Jun 23; 157(12):1330-6. PubMed ID: 9201007
    [Abstract] [Full Text] [Related]

  • 9. [Estrogen therapy for the climateric and thromboembolic risk].
    Campagnoli C, Prelato L, Rossetti MG.
    Minerva Ginecol; 1980 May 23; 32(5):429-35. PubMed ID: 7393492
    [Abstract] [Full Text] [Related]

  • 10. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH.
    N Engl J Med; 1991 Sep 12; 325(11):756-62. PubMed ID: 1870648
    [Abstract] [Full Text] [Related]

  • 11. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives.
    Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD.
    N Engl J Med; 1981 Aug 20; 305(8):420-4. PubMed ID: 7254279
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD.
    Am Heart J; 2008 Apr 20; 155(4):706-11. PubMed ID: 18371480
    [Abstract] [Full Text] [Related]

  • 18. The impact of estrogen on cardiovascular disease. Prospective studies: The Framingham Study.
    Wilson PW.
    Postgrad Med; 1989 Apr 20; Spec No():51-3; discussion 89-90. PubMed ID: 2542911
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.